Pfizer concludes acquisition of Hospira

05 Sep 2015 Evaluate

Pfizer has completed its acquisition of Hospira, Inc. on September 03, 2015, creating a leading Global Established Pharmaceutical (GEP) Business. Hospira is the world’s leading provider of injectable drugs and infusion technologies and a global leader in biosimilars.

Pfizer has produced innovative breakthroughs in a wide range of research areas, including depression, erectile dysfunction, high cholesterol, HIV infection, hypertension, bacterial infections and systemic fungal infections.


Pfizer Share Price

5049.50 17.75 (0.35%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×